$100 Billion Of US And European Pharmaceutical Company Revenues Threatened By Generic Drugs Forecasts URCH Publishing

... Over $100 billion in revenue of major branded drugs is under threat from new generic products as patents expire over the next five years. The most dramatic change in this period will arise in the period 2010-12 as the patents covering Pfizer's best-seller Lipitor expire, predicts a new report 'Generic Competition 2007 to 2011 -- The impact of patent expiries on sales of major drugs. [click link for full article] ...